DXB vs MSB

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

DXB

DIMERIX FPO [DXB]

40LOW

MSB

MESOBLAST FPO [MSB]

46LOW

Score Breakdown

DXB MSB
Technical
45
70
Catalyst
48
82
Sentiment
50
50
Fundamental
82
78
Momentum
36
60
Risk Gate
50
40

Key Metrics

DXB Metric MSB
$141.1MMarket Cap$3.0B
3.2MAvg Volume (20d)3.8M
N/AShort Interest+8.4%
$0.66552-Week High$3.310
$0.15852-Week Low$1.630
+2.1%Daily Change+0.8%
$0.240Reference Price$2.370
-594.5%ROE-18.2%
-219.9%Profit Margin-144.3%

Active Signals

DXB Signals

●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Beating the Small Ords index — relative strength of 1.36, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●4C filed 2026-04-29
●Strong revenue growth (+636%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (15% of range)

MSB Signals

●MACD momentum is picking up steam
●Stochastic is stretched into overbought — could need a breather
●Pressing against the upper Bollinger Band — extended and may need to cool off
●Trading above both moving averages — the trend is your friend here
●On a tear — up 17.3% over the last 5 days
●Beating the Small Ords index — relative strength of 1.29, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (9 quarters)

Ask Scout AI to compare DXB and MSB in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

DXB vs MVF →DXB vs OSL →DXB vs PYC →DXB vs RAC →DXB vs RNV →
DXB Full Analysis → MSB Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).